Browse studies

Find your next paid study

27,384 recruiting studies available now

A Modular, Multi-Part, Multi-Arm, Phase 1/2 Study to Evaluate the Safety and Tolerability of CT7439 Alone and in Combination With Anticancer Treatments in Participants With Solid Malignancies

This modular, multi-part, multi-arm, Phase 1/2, FIH study allows the evaluation of the safety and tolerability of CT7439, dosed as a monotherapy and in combina…

Solid Malignancies

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Carrick Therapeutics LimitedNCT06600789

Establishing Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type 1 (END-DM1) Extension

Myotonic Dystrophy type 1 (DM1) is an autosomal dominant multisystemic disorder that causes progressive disability and shortened life expectancy. It is charact…

DM1Myotonic DystrophyMyotonic Dystrophy 1+4 more

Estimated

~$10 – $750

Actual pay is set by the research site.

Virginia Commonwealth UniversityNCT07700225

Phase 1

Efficacy of Combined Ibuprofen and Acetaminophen Therapy Versus Ibuprofen Alone Versus Placebo Alone for Pain of Initial Orthodontic Wire Insertion: a Randomized Controlled Trial

The purpose of this study is to compare the effectiveness of a combined ibuprofen and acetaminophen regimen in controlling discomfort for 4 days after initial …

Pain, Orofacial

Estimated

~$500 – $7,500

Actual pay is set by the research site.

University of Colorado, DenverNCT04059172

Phase 1

Study of NMS-03305293, a Non-Trapping PARP1-Specific PARP Inhibitor in Relapsed Ovarian Cancer

This is a multicenter, open-label Phase Ia/b study on the safety and efficacy of the combination of NMS-03305293 and topotecan in patients with recurrent ovari…

Ovarian Cancer

Estimated

~$150 – $4,500

Actual pay is set by the research site.

Nerviano Medical SciencesNCT06930755

Phase 1

Mesenchymal Stem Cell Extracellular Vesicles for the Treatment of Recessive Dystrophic Epidermolysis Bullosa Wounds

INVESTIGATIONAL PRODUCT: AGLE-102 is an allogeneic extracellular vesicle (EV) product derived from normal donor mesenchymal stem cells (MSCs). INDICATION AND …

Dystrophic Epidermolysis Bullosa

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Aegle TherapeuticsNCT04173650

Investigating -Omic Features and Prognostic Indicators of Cervical Spondylotic Myelopathy

Investigators believe that patients with cervical spondylotic myelopathy (CSM) have measurable changes in certain molecules in their blood compared with people…

Cervical Spondylotic Myelopathy

Estimated

~$10 – $675

Actual pay is set by the research site.

University of California, San FranciscoNCT07772297

Phase 2

Adaptive Platform Trial to Delay Progression From Stage 2 to Stage 3 Type 1 Diabetes: Comparing Teplizumab With Low-dose Anti-Thymocyte Globulin (ATG) Protocol TN-40A

This is a 2-arm, multi-center, open label study to learn if ATG works the same or better than teplizumab in delaying or preventing Stage 3 Type 1 diabetes. Par…

Type 1 Diabetes Mellitus

Estimated

~$75 – $1,800

Actual pay is set by the research site.

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NCT07216391

A Long-Term Follow-Up Study of Subjects Completing the AU-011-301 (CoMpass) Trial of Bel-sar for Early Choroidal Melanoma (Indeterminate Lesions/Small Choroidal Melanomas)

AU-011-403 is a multicenter long-term follow-up safety and efficacy study of subjects with early CM who previously participated in the AU-011-301 Phase 3 trial…

Choroidal MelanomaIndeterminate Lesions

Estimated

~$10 – $1,050

Actual pay is set by the research site.

Aura BiosciencesNCT07338968

Observational

Fostering Oral Chemotherapy Understanding and Safety (FOCUS) Qualitative Study: Utilization of an Adherence Application

The purpose of this study is to learn about the experiences of cancer patients during treatment utilizing a mobile app called EveryDose© to track prescribed or…

Cancer

Estimated

~$10 – $750

Actual pay is set by the research site.

University of MiamiNCT06952790

Observational

Radicle Energy VBMTM: A Randomized, Double-Blind, Placebo-Controlled Study Assessing the Impact of Health and Wellness Products on Fatigue and Related Health Outcomes

Radicle Energy VBMTM: A randomized, double-blind, placebo- controlled direct-to-consumer study assessing the impact of health and wellness products on fatigue …

FatigueCognitive FunctionGlobal Mental Health+1 more

Estimated

~$10 – $1,125

Actual pay is set by the research site.

Radicle ScienceNCT07653724

Phase 4

Houston Emergency Opioid Engagement System (HEROES)

The Houston Emergency Response Opioid Engagement System (HEROES) is a community-based research program integrating assertive outreach, medication-assisted trea…

Opioid Use Disorder

Estimated

~$25 – $1,000

Actual pay is set by the research site.

The University of Texas Health Science Center, HoustonNCT03396276

Observational

Implementing A Secure Firearm Storage Program in Illinois Health Centers in Partnership With AllianceChicago and the Illinois Primary Health Care Association (COMMUNITY ASPIRE)

This randomized controlled trial will take place in up to 15 community health centers across the state of Illinois. Researchers will be studying S.A.F.E. Firea…

Suicide

Estimated

~$10 – $750

Actual pay is set by the research site.

Northwestern UniversityNCT06886776